Page breadcrumb nav

VAERS Report 2157203

Case Report Section

Détails du rapport Vaer

Âge: 42 ans

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (MODERNA))

Type : Coronavirus 2019 vaccine

Fabricant: MODERNA

Lot: 216037


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2022-01-25
Date d’apparition
1
Nombre de jours (date d’apparition – date de vaccination)
1
Description de l’événement indésirable

first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest; first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest.; first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest.; first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest.; this case was received via regulatory authority (reference number: it-regulatory authority02-840309) on 23-feb-2022 and was forwarded to moderna on 23-feb-2022. this regulatory authority case was reported by a consumer and describes the occurrence of back pain (first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest), pain in extremity (first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest.), muscle twitching (first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest.) and tachycardia (first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest.) in a 42-year-old female patient who received mrna-1273 (spikevax) (batch no. 216037) for sars-cov-2 vaccination. concurrent medical condition included hypertension, nichel allergy and mild essential tremor. previously administered products included for product used for unknown indication: comirnaty (biontech manufacturing gmbh) (j07bx03 on 16-jul-2021 and comirnaty (biontech manufacturing gmbh) (j07bx03 on 22-aug-2021.past adverse reactions to the above products included no adverse event with comirnaty (biontech manufacturing gmbh) (j07bx03 and comirnaty (biontech manufacturing gmbh) (j07bx03.concomitant products included irbesartan for an unknown indication.on 25-jan-2022, the patient received dose of mrna-1273 (spikevax) (intramuscular) 1 dosage form. on 26-jan-2022, the patient experienced back pain (first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest) (seriousness criterion hospitalization), pain in extremity (first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest.) (seriousness criterion hospitalization), muscle twitching (first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest.) (seriousness criterion hospitalization) and tachycardia (first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest.) (seriousness criterion hospitalization). at the time of the report, back pain (first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest), pain in extremity (first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest.), muscle twitching (first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest.) and tachycardia (first aid hospitalization with muscle contractions and leg pain, back from the day after inoculated vaccine moderna third dose, day 3 strong tachycardia with pressure throat and chest.) was resolving. the action taken with mrna-1273 (spikevax) (intramuscular) was unknown. treatment information was unknown. this is a regulatory case concerning a 42-year-old female patient with no relevant medical history, who experienced the unexpected serious events of back pain, muscle twitching, pain in extremity, and tachycardia. the events led to the hospitalization of the patient as reported by the regulatory authority. the events occurred in 1 day after receiving an unspecified dose of mrna-1273 vaccine. no clinical or treatment details were given. it was reported that the outcome of the event was resolving. the benefit-risk relationship of mrna-1273 vaccine is not affected by this report. sender's comments: this is a regulatory case concerning a 42-year-old female patient with no relevant medical history, who experienced the unexpected serious events of back pain, muscle twitching, pain in extremity, and tachycardia. the events led to the hospitalization of the patient as reported by the regulatory authority. the events occurred in 1 day after receiving an unspecified dose of mrna-1273 vaccine. no clinical or treatment details were given. it was reported that the outcome of the event was resolving. the benefit-risk relationship of mrna-1273 vaccine is not affected by this report

Données de laboratoire
na
Liste des symptômes
muscle twitching back pain pain in extremity tachycardia
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Unknown
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Oui
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
na